{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-26-001384","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2026-08-17T16:37:43+00:00","discovered_at":"2026-08-17T16:39:05.342942+00:00","generated_at":"2026-08-17T16:39:26.174832+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lexaria regains Nasdaq bid price compliance; hearing cancelled, stock remains listed","bullets":["Received Nasdaq letter on Aug 17, 2026 confirming compliance with Rule 5550(a)(2) bid price requirement.","Previously requested hearing before Nasdaq Hearings Advisor has been cancelled.","Common stock (LEXX) continues trading on The Nasdaq Capital Market without interruption."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-26-001384","json":"https://secwatch.observer/filing/0001640334-26-001384.json","markdown":"https://secwatch.observer/filing/0001640334-26-001384.md","text":"https://secwatch.observer/filing/0001640334-26-001384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033426001384/0001640334-26-001384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033426001384/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-17T16:39:26.174832+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}